FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Watson Laboratories Carisoprodol Tablets Recall

Carisoprodol Tablets, USP, CIV, 350 mg, 500 count bottle, Rx only

Watson Laboratories Inc · Corona, CA

Risk level
Class II
Reported by FDA
Jan 15, 2014
Recall ID
D-397-2014
Check your lot numberHow we source this data

Summary

Watson Laboratories recalled Carisoprodol Tablets starting Dec 23, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-397-2014 on Jan 15, 2014. Reason: Presence of Foreign Substance; metal particulates were visually observed in the tablets. Status: Terminated.

Why it was recalled

Presence of Foreign Substance; metal particulates were visually observed in the tablets.

Product description

Carisoprodol Tablets, USP, CIV, 350 mg, 500 count bottle, Rx only. Manufactured by Watson Pharma Private Ltd, Verna, Salcette, Goa, 403 722 INDIA. Distributed by: Watson Pharma Ltd, Parsippany, NJ 07054. NDC 0591-5513-05.

Lot numbers, UPCs & expiration codes

Lot # 244152A, exp 01/15.

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-397-2014
Classification
Class II
Status
Terminated
Recall initiated
Dec 23, 2013
FDA report date
Jan 15, 2014
Quantity
4,439 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Watson Laboratories Inc

Original FDA data

Every field from FDA enforcement report D-397-2014, exactly as published.

Show all FDA fields
City
Corona
State
CA
Status
Terminated
Country
United States
Event ID
67200
Address
132 Business Center Dr
Code information
Lot # 244152A, exp 01/15.
Postal code
92880-1724
Report date
Jan 15, 2014
Product type
Drugs
Recall number
D-397-2014
Classification
Class II
Recalling firm
Watson Laboratories Inc
Product quantity
4,439 bottles
Termination date
Aug 4, 2014
Reason for recall
Presence of Foreign Substance; metal particulates were visually observed in the tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Carisoprodol Tablets, USP, CIV, 350 mg, 500 count bottle, Rx only. Manufactured by Watson Pharma Private Ltd, Verna, Salcette, Goa, 403 722 INDIA. Distributed by: Watson Pharma Ltd, Parsippany, NJ 07054. NDC 0591-5513-05.
Distribution pattern
Nationwide
Recall initiation date
Dec 23, 2013
Initial firm notification
Letter
Center classification date
Jan 6, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-397-2014, published Jan 15, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls